Procaps Group, S.A Revenue 2020-2023 | PROCF
Procaps Group, S.A revenue from 2020 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Procaps Group, S.A Annual Revenue
(Millions of US $) |
| 2022 |
$410 |
| 2021 |
$410 |
| 2020 |
$331 |
| 2020 |
$ |
| 2019 |
$325 |
| 2019 |
$ |
| 2018 |
$ |
Procaps Group, S.A Quarterly Revenue
(Millions of US $) |
| 2023-09-30 |
$118 |
| 2023-06-30 |
$110 |
| 2023-03-31 |
$84 |
| 2022-12-31 |
$101 |
| 2022-09-30 |
$110 |
| 2022-06-30 |
$112 |
| 2022-03-31 |
$86 |
| 2021-12-31 |
$127 |
| 2021-09-30 |
$107 |
| 2021-06-30 |
$99 |
| 2021-03-31 |
$77 |
| 2020-12-31 |
$252 |
| 2020-09-30 |
$79 |
| 2020-06-30 |
|
| 2020-03-31 |
|
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
